✦ LIBER ✦

Buccal Absorption of Midazolam: Pharmacokinetics and EEG Pharmacodynamics

✍ Scribed by Rod C. Scott; Frank M. C. Besag; Stewart G. Boyd; David Berry; Brian G. R. Neville

Book ID: 109106646
Publisher: Wiley (Blackwell Publishing)
Year: 1998
Tongue: English
Weight: 540 KB
Volume: 39
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1157.1998.tb01375.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simultaneous modeling of the pharmacokin

Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam

✍ Mould, Diane R.; DeFeo, Tina Marie; Reele, Stots; Milla, Grace; Limjuco, Raul; C 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 730 KB

Impact of theCYP3A5genotype on midazolam

Impact of theCYP3A5genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation

✍ Martin F. Fromm; Helmut Schwilden; Iouri Bachmakov; Jörg König; Frank Bremer; Jü 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 127 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of low doses of midazolam administered intravenously and orally to healthy volunteers

✍ Shingen Misaka; Shinya Uchida; Hiromitsu Imai; Naoki Inui; Shinichiro Nishio; Ky 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 502 KB

Pharmacokinetic-pharmacodynamic modeling

Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system

✍ Koopmans, R; Dingemanse, J; Danhof, M; Horsten, G P M; van Boxtel, C J 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 658 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of azosemide

✍ Ok K. Suh; So H. Kim; Myung G. Lee 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of levodopa

✍ John G. Nutt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

The pharmacokinetics and pharmacodynamics of levodopa are dominated by two features: the short plasma half-life of the drug and the portion of the antiparkinsonian response that parallels the plasma levodopa levels, the socalled short-duration response. These features are the basis of motor fluctuat